相关实验视频

Updated: Jul 19, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

微RNA-326在肺腺癌中负面调节CD155的表达

Takayuki Nakanishi¹, Yasuto Yoneshima¹, Koji Okamura¹

¹Department of Respiratory Medicine, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.

|August 11, 2023

概括

微RNAs调节CD155表达,这是非小细胞肺癌中对PD-1/PD-L1抑制剂的抵抗机制. 确定了miR-326作为一个关键的调节器,为克服耐药性提供了潜在的治疗点.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
免疫治疗是一种免疫疗法.

背景情况:

像PD-1/PD-L1抑制剂这样的免疫检查点抑制剂 (ICI) 在非小细胞肺癌 (NSCLC) 中显示出持久的反应.
对ICI的耐药性是NSCLC治疗中的一个重大临床挑战.
CD155表达的上调是一种已知的机制,有助于ICI耐药性.

研究的目的:

为了确定微RNAs (miRNAs) 在肺癌中后转录调节CD155表达.
研究特定miRNAs在控制瘤细胞中CD155水平中的作用.
探索潜在的治疗策略,针对miRNA介导的CD155调节以克服ICI耐药性.

主要方法:

使用了全面的miRNA查和目标预测程序.
双露西法酶记者测试被用来验证miRNA与CD155的结合. mRNA.
免疫组织化学染色评估了患者瘤样本中的CD155表达.

主要成果:

四个miRNAs (miR-346,miR-328-3p,miR-326,miR-330-5p) 被确定与CD155mRNA的3'-UTR结合.
这些miRNAs的强制表达抑制了肺癌细胞系中的CD155表达.
在肺腺癌组织中观察到miR-326丰度和CD155表达水平之间存在显著的反相关性.

结论:

miR-326在肺腺癌中负面调节CD155的表达.
这种miRNA介导的调节表明miR-326在调节对PD-1/PD-L1抑制剂的耐药性方面发挥了作用.
向miR-326可能代表了一种新的治疗方法,以提高ICI在NSCLC中的疗效.

关键词:

CD155 是一个CD155 是一个CD155 肺部腺癌瘤是什么在 miR-32626 里面.这是一个微型RNA.类似于尼丁的分子5 (Necl5)脊髓灰质炎病毒受体 (PVR)

更多相关视频

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Adenoviral Transduction of Naive CD4 T Cells to Study Treg Differentiation

Published on: August 13, 2013

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library

Published on: April 6, 2012

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...

Master Transcription Regulators

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...